Sign in
Taking people in United StatesNo phase

Tests virtual reality as added pain relief during sickle cell pain crises

Tests virtual reality added to standard care for pain in people with sickle cell disease.

Key facts

Who runs it
St. Jude Children's Research Hospital
Where
Memphis, United StatesSee the 2 sites
Trial code
Registry title
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Status
Recruiting
People taking part
76 people, planned
Started
5 Feb 2018
Expected to end
Nov 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Virtual Reality Therapy
Record updated
18 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young adults with sickle cell disease who come to St. Jude Children's Research Hospital with a pain crisis. It tests virtual reality added to usual pain care.

Age
6 to 25 years
Sex
All sexes can join.
Disease stage
Sickle cell disease of any genotype, with an acute vaso-occlusive crisis (pain crisis). Pain score of 4 or more, with opioid treatment indicated.
Earlier treatment
Cannot be in another pain management trial for the same pain crisis, and cannot have been randomized in this study before.

Main reasons for not taking part

  • Mild pain (score below 4) or pain that does not need opioid treatment
  • Pain together with other symptoms needing extra care, such as fever with focus, acute chest syndrome, acute injury or splenic sequestration
  • Developmental or psychiatric disorders (such as autism or claustrophobia) or vision or hearing problems that prevent use of a head mounted device
  • Not English speaking
  • Cannot or will not give written informed consent

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Participant must have sickle cell disease (any genotype), documented in the St. Jude medical record
  • Participant must be seeking care for acute VOC pain at St. Jude Children's Research Hospital
  • Participant age must be ≥ 6 years and ≤ 25 years
  • English speaking

Who cannot take part

  • Prior randomization in this study
  • Mild pain (score <4), or pain for which treatment with opioid is not indicated
  • Pain in combination with other clinical symptoms that require additional interventions, including fever with focus, acute chest syndrome, acute injury, or splenic sequestration
  • Developmental or psychiatric disorders like autism, claustrophobia or other disabilities like vision and hearing defects etc. that preclude the use of a head mounted device
  • Patients are currently enrolled on another pain management interventional trial for the presenting pain crisis
  • Inability or unwillingness of research participant or legal guardian/ representative to give written informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 25 years old?

Where in United States

  • St. Jude Children's Research HospitalMemphis, United StatesContact: Michael Frett, MDTaking people
  • Methodist Comprehensive Sickle Cell CenterMemphis, United StatesContact: Michael Frett, MDNo longer taking part

About the trial

What the trial wants to find out

Acute vaso-occlusive crisis (VOC) is the most common complication in patients with sickle cell disease (SCD) and pain related to VOC is often inadequately treated. This is a phase II randomized controlled clinical trial evaluating the efficacy of virtual reality technology when added to standard pain management for patients with sickle cell disease who are experiencing acute pain crisis in the ambulatory care setting. Patients will be randomized to receive either standard management only or standard management in addition to virtual reality therapy. The remainder of care for the painful event will continue per institutional standards according to clinical indication, including reassessment and documentation of pain and additional doses of pain medicines by intravenous (IV) or oral route. Pain scores and opioid requirement will be measured and compared across treatment arms, along with the outcomes of discharge from clinic versus admission to the inpatient unit.

Read full original descriptionShow less

PRIMARY OBJECTIVE: To assess the efficacy of virtual reality (VR) technology in reducing pain at 30 minutes after intervention during an acute vaso-occlusive crisis in patients with sickle cell disease. Primary endpoint will be change in pain scores in Standard versus VR arms, between the first pain assessment at the time of presentation and the subsequent pain assessments up to 30 minutes after intervention.

Secondary Objectives:

* To compare total opioid consumption from the time of presentation to the time of discharge from acute care setting in Standard versus VR arms. * To assess the efficacy of virtual reality (VR) technology in reducing pain at 60 minutes after the first IV medication administered or 60 minutes after completion VR during an acute vaso-occlusive crisis in patients with sickle cell disease.

The 2 groups in the trial

  • Standard CareNo study treatment, for comparison

    Participants receive standard care treatment for their vaso-occlusive crisis. Participants will be randomized by age.

  • Virtual RealityExisting treatment, for comparison

    Participants receive standard care treatment for their vaso-occlusive crisis. In addition, they will have a 15-minute Virtual Reality Therapy session. Participants will be randomized by age.

    Treatment: Virtual Reality Therapy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Pain Management of Vaso-Occlusive Crisis in Children and Young Adults With Sickle Cell Disease-Effect of Virtual Reality Technology
Plain-language title
Tests virtual reality as added pain relief during sickle cell pain crisesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT03353584, who can take part
Record updated
18 May 2026